Human Thrombin Activatable Fibrinolysis Inhibitor

Human Thrombin Activatable Fibrinolysis Inhibitor, 0,1 mg
Artikelnummer
MOITAFI-0,1
Verfügbarkeit: wird geladen...
Preis wird geladen...
Molecular Weight: 58000
Storage Buffer: 0.02M Hepes; 0.2M NaCl; pH 7.4
Source: Human plasma
Extinction coefficient: 2,2
Purity: >95% by SDS-PAGE analysis
Gene: CPB2
Swiss ID: Q96IY4
Description: Thrombin Activatable Fibrinolysis Inhibitor (TAFI), also known as plasma procarboxypeptidase-B and carboxypeptidase-U, is a single chain glycoprotein that is cleaved by thrombin, plasmin and trypsin. TAFI is purified from normal human plasma using immunoaffinity and ion-exchange chromatography. Activated TAFI cleaves C-terminal lysines on fibrin and cell surfaces resulting in down-regulation of fibrinolysis by reducing the number of plasminogen and tPA binding sites on fibrin.
Mehr Informationen
Artikelnummer MOITAFI-0,1
Hersteller Molecular Innovations
Hersteller Artikelnummer TAFI-0,1
Verpackungseinheit 0,1 mg
Mengeneinheit FL
Reaktvität Human
Human Gene ID 1361
Datenblatt
×
MSDS Download